Christopher R. D’Angelo

1.1k total citations
36 papers, 181 citations indexed

About

Christopher R. D’Angelo is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Christopher R. D’Angelo has authored 36 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 9 papers in Molecular Biology. Recurrent topics in Christopher R. D’Angelo's work include Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Christopher R. D’Angelo is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Christopher R. D’Angelo collaborates with scholars based in United States, Italy and Spain. Christopher R. D’Angelo's co-authors include Natalie S. Callander, Sailendharan Sudakaran, Dalia El‐Gamal, Nicolaas Schaap, Emérito Amaro-Carambot, Peiman Hematti, Alexander C. Schmidt, Peter L. Collins, L. El-Guebaly and Bruce A. Pint and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher R. D’Angelo

29 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher R. D’Angelo United States 9 54 50 48 40 31 36 181
John A. Ligon United States 10 23 0.4× 41 0.8× 105 2.2× 25 0.6× 34 1.1× 32 215
Luigi Cinquanta Italy 7 33 0.6× 67 1.3× 7 0.1× 54 1.4× 44 1.4× 21 250
Baosong Xie China 9 46 0.9× 38 0.8× 33 0.7× 54 1.4× 21 0.7× 31 181
Célestine Simand France 8 57 1.1× 27 0.5× 58 1.2× 72 1.8× 25 0.8× 20 223
Maria E. Kempner United States 6 36 0.7× 25 0.5× 28 0.6× 38 0.9× 24 0.8× 11 171
Johannes Kläger Austria 7 46 0.9× 20 0.4× 39 0.8× 27 0.7× 35 1.1× 29 239
Danielle E. Arnold United States 7 36 0.7× 66 1.3× 56 1.2× 33 0.8× 144 4.6× 18 255
Sen Mui Tan Malaysia 7 39 0.7× 32 0.6× 33 0.7× 12 0.3× 60 1.9× 22 133
Masaharu Tamaki Japan 9 67 1.2× 17 0.3× 50 1.0× 26 0.7× 53 1.7× 48 201
Graeme Quest Canada 6 24 0.4× 32 0.6× 19 0.4× 25 0.6× 69 2.2× 11 137

Countries citing papers authored by Christopher R. D’Angelo

Since Specialization
Citations

This map shows the geographic impact of Christopher R. D’Angelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. D’Angelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. D’Angelo more than expected).

Fields of papers citing papers by Christopher R. D’Angelo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. D’Angelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. D’Angelo. The network helps show where Christopher R. D’Angelo may publish in the future.

Co-authorship network of co-authors of Christopher R. D’Angelo

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. D’Angelo. A scholar is included among the top collaborators of Christopher R. D’Angelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. D’Angelo. Christopher R. D’Angelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
D’Angelo, Christopher R., et al.. (2025). Mantle cell lymphoma: from pathogenesis to treatment for 2024 and beyond. Panminerva Medica. 67(2). 59–71. 1 indexed citations
3.
Wang, Bing, Heather Rasmussen, Sathish Kumar Natarajan, et al.. (2025). Urinary metabolites as biomarkers of dietary intake: a systematic review. Frontiers in Nutrition. 12. 1596543–1596543.
4.
Ellithi, Moataz, Magdi Elsallab, Matthew A. Lunning, et al.. (2024). Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data. Transplantation and Cellular Therapy. 31(2). 71.e1–71.e14. 11 indexed citations
5.
Rana, Sandeep, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.. (2024). Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer Research Communications. 4(5). 1328–1343. 2 indexed citations
6.
Shostrom, Valerie, Jamés O. Armitage, Julie Vose, et al.. (2024). Impact of Icans on Long-Term Neurocognitive Function in Patients with Diffuse Large B-Cell Lymphoma Receiving CAR T-Cell Therapy. Blood. 144(Supplement 1). 2368–2368.
7.
D’Angelo, Christopher R., Charles A. Enke, Julie M. Vose, et al.. (2024). A Prospective Clinical Trial of Boom-Boom Radiation As Bridging Therapy for Patients with Large B-Cell Lymphoma Undergoing Treatment with Lisocabtagene Maraleucel (Liso-cel) Therapy. Blood. 144(Supplement 1). 3126–3126. 2 indexed citations
8.
D’Angelo, Christopher R., Avyakta Kallam, Matthew A. Lunning, et al.. (2024). BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia. JCI Insight. 9(10). 6 indexed citations
9.
10.
El‐Gamal, Dalia, et al.. (2023). Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies. International Journal of Molecular Sciences. 24(3). 2309–2309. 11 indexed citations
11.
12.
D’Angelo, Christopher R., et al.. (2023). The shifting roles and toxicities of cellular therapies in B‐cell malignancies. Transplant Infectious Disease. 25(S1). e14145–e14145. 2 indexed citations
13.
D’Angelo, Christopher R., Sailendharan Sudakaran, Fotis Asimakopoulos, et al.. (2022). Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. Leukemia & lymphoma. 64(1). 87–97. 18 indexed citations
14.
15.
D’Angelo, Christopher R., et al.. (2019). Intravascular large B-cell lymphoma presenting with altered mental status: A case report. World Journal of Clinical Oncology. 10(12). 402–408. 4 indexed citations
16.
D’Angelo, Christopher R., et al.. (2017). 959: INVESTIGATING THE INFLUENCE OF CAFFEINE INTAKE AND THE INCIDENCE OF ICU DELIRIUM. Critical Care Medicine. 46(1). 463–463. 1 indexed citations
17.
D’Angelo, Christopher R., Masha Kocherginsky, Jennifer Pisano, et al.. (2015). Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment. Leukemia & lymphoma. 57(8). 1807–1813. 11 indexed citations
18.
Schaap, Nicolaas, Christopher R. D’Angelo, Emérito Amaro-Carambot, et al.. (2010). Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. Virology. 406(1). 65–79. 8 indexed citations
19.
Schaap, Nicolaas, Christopher R. D’Angelo, Margaret A. Scull, et al.. (2009). Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates. Virology. 397(2). 285–298. 16 indexed citations
20.
Leggio, Lorenzo, Ludovico Abenavoli, Christopher R. D’Angelo, et al.. (2006). Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites. Digestive Diseases and Sciences. 51(9). 1644–1646. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Ligon Breakdown of academic impact, for papers by Luigi Cinquanta Breakdown of academic impact, for papers by Baosong Xie Breakdown of academic impact, for papers by Célestine Simand Breakdown of academic impact, for papers by Maria E. Kempner Breakdown of academic impact, for papers by Johannes Kläger Breakdown of academic impact, for papers by Danielle E. Arnold Breakdown of academic impact, for papers by Sen Mui Tan Breakdown of academic impact, for papers by Masaharu Tamaki Breakdown of academic impact, for papers by Graeme Quest
Rankless by CCL
2026